NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Differences between human plasma and serum metabolite profiles.

Author(s): Yu Z, Kastenmüller G, He Y, Belcredi P, Möller G, Prehn C, Mendes J, Wahl S, Roemisch-Margl W, Ceglarek U, Polonikov A, Dahmen N, Prokisch H, Xie L, Li Y, Wichmann HE, Peters A, Kronenberg F, Suhre K, Adamski J, Illig T, Wang-Sattler R

Publication: PLoS One, 2011, Vol. 6, Page e21230

PubMed ID: 21760889 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of patient gender, smoking status, and a diagnosis of type 2 diabetes as well as blood component analyzed (EDTA plasma versus serum) on the concentrations of 122 metabolites.

Conclusion of Paper

The concentrations of 122 metabolites showed strong correlations with previous results when analyses were repeated for both plasma and serum specimens, but the reproducibility was significantly higher in plasma specimens. The concentrations of 85% of the 122 metabolites were significantly higher in serum than in plasma, but an overall strong correlation between the two types of specimens was observed. A greater number of metabolites were found to be differentially expressed between patients with type 2 diabetes and those without, males versus females, and smokers versus non-smokers when serum was analyzed rather than plasma.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of patient gender, smoking status, and a diagnosis of type 2 diabetes as well as blood component analyzed (EDTA plasma versus serum) on the concentrations of 122 metabolites. Specimens were drawn into either serum or EDTA plasma gel tubes, and plasma and serum were processed and frozen at -80 degrees C within 30-60 min of collection. Metabolic analysis was performed using the AbsoluteIDQ kit p150 and flow injection analysis mass spectrometry (FIA-MS).

    Summary of Findings:

    The concentrations of 122 metabolites showed strong correlations with previous results when analyses were repeated for both plasma (r=0.83) and serum specimens (r=0.80), but the reproducibility was significantly higher in plasma specimens (p=0.01). The concentrations of 85% of the 122 metabolites were significantly higher in serum than in plasma, but an overall strong correlation between the two types of specimens was observed (r=0.81). A greater number of metabolites were found to be differentially expressed between patients with type 2 diabetes and those without, males versus females, and smokers versus non-smokers when serum was analyzed rather than plasma.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Diabetes Type 2
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Lipid LC-MS or LC-MS/MS
    Small molecule LC-MS or LC-MS/MS
    Carbohydrate LC-MS or LC-MS/MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Other drugs Smoker
    Non-smoker
    Preaquisition Patient gender Female
    Male
    Preaquisition Diagnosis/ patient condition Type 2 diabetes
    No type 2 diabetes
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...